Santen Pharmaceutical Co Ltd 2021 Integrated Report
The report presents Santen's FY2020 consolidated performance and integrated strategy. It identifies four ESG materialities as key management issues and reports initiatives to improve diversity, equity and inclusion, including greater senior-management diversity. Environmental priorities include carbon neutrality toward 2050 and a 50% reduction in Scope 1 and 2 emissions by 2030 versus 2019. Consolidated revenue for the year ended March 31, 2021 was JPY 249.6 billion.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2021
Type: Integrated Report
Pages: 83
Back to company
Santen Pharmaceutical Co Ltd
Santen Report
The report presents Santen's FY2020 consolidated performance and integrated strategy. It identifies four ESG materialities as key management issues and reports initiatives to improve diversity, equity and inclusion, including greater senior-management diversity. Environmental priorities include carbon neutrality toward 2050 and a 50% reduction in Scope 1 and 2 emissions by 2030 versus 2019. Consolidated revenue for the year ended March 31, 2021 was JPY 249.6 billion.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2020
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Net Zero Target
Employees